Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Royalty Pharma PLC Transaction History

Mitsubishi Ufj Morgan Stanley Securities Co., Ltd.

  • $7.89 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$42.34 - $52.82 $82,563 - $102,999
-1,950 Closed
0 $0
Q4 2020

Feb 17, 2021
BUY
$36.12 - $50.05 $70,434 - $97,597
1,950 New
1,950 $98,000

Others Institutions Holding RPRX

# of Institutions
413
Shares Held
283M
Call Options Held
578K
Put Options Held
47.5K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $13.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Portfolio

Follow Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Morgan Stanley Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email